List of articles in "Drug" category - Page 94

EBC-46 is a natural chemical currently being studied for the treatment of some types of cancer (mainly limited at this stage to non-metastasised solid tumours) in both animals and humans. […]

Cannabicyclohexanol (CCH CP 47497 dimethyloctyl homologue (C8)-CP 47497) is a cannabinoid receptor agonist drug developed by Pfizer in 1979. On 19 January 2009 the University of Freiburg in Germany announced […]

CECXG (3′-ethyl-LY-341495) is a research drug which acts as a potent and selective antagonist for the group II metabotropic glutamate receptors (mGluR2/3) with reasonable selectivity for mGluR3. While it is […]

CY-208243 is a drug which acts as a dopamine agonist selective for the D1 subtype. Unlike most D1-selective agonists it shows efficacy in animal models of Parkinson’s disease.

Iodine (125I) CC49 is an iodine-125 radiolabelled monoclonal antibody for the detection of tumours. It is used in radioimmunoassays such as CA 72-4.CC49 has also been tested for the treatment […]

Atacicept is a recombinant fusion protein designed to inhibit B cells thereby suppressing autoimmune disease. The designer protein combines the binding site for two cytokines that regulate maturation function and […]

Chlorophenylbiguanide (1-(3-Chlorophenylbiguanide m-CPBG) is an agonist for the 5HT3 receptor and an antagonist for the Alpha-2A adrenergic receptor. It has anxiogenic emetic and hypothermic effects in animal studies.

BRL-54443 is a drug which acts as a selective agonist for the 5-HT1E and 5-HT1F serotonin receptor subtypes.

P7C3 is a drug related to latrepirdine (dimebon) which has neuroprotective and proneurogenic effects and may be potentially useful for the treatment of Alzheimer’s disease and similar neurodegenerative disorders.

Metaflumizone is a semicarbazone insecticide indicated for the veterinary treatment of fleas and ticks marketed under the brand name ProMeris.A discontinued variant of ProMeris called ProMeris Duo or Promeris for […]